Trek Therapeutics trialling promising new NS5A inhibitor Jun 21, 2016 18:08:14 GMT Quote Select PostDeselect PostLink to PostMemberGive GiftBack to Top Post by Admin on Jun 21, 2016 18:08:14 GMT www.pharmalive.com/trek-therapeutics-initiates-phase-2a-study-of-faldaprevir-and-td-6450-with-and-without-ribavirin-in-patients-with-hcv-gt-1b/